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Abstract
Background: The risk of falling is significantly higher in people with chronic stroke and it is, therefore, important to
design interventions to improve mobility and decrease falls risk. Minimum toe clearance (MTC) is the key gait cycle
event for predicting tripping-falls because it occurs mid-swing during the walking cycle where forward velocity of
the foot is maximum.
High forward velocity coupled with low MTC increases the probability of unanticipated foot-ground contacts.
Training procedures to increase toe-ground clearance (MTC) have potential, therefore, as a falls-prevention
intervention. The aim of this project is to determine whether augmented sensory information via real-time
visual biofeedback during gait training can increase MTC.
Methods: Participants will be aged > 18 years, have sustained a single stroke (ischemic or hemorrhagic) at
least six months previously, able to walk 50 m independently, and capable of informed consent. Using a
secure web-based application (REDCap), 150 participants will be randomly assigned to either no-feedback
(Control) or feedback (Experimental) groups; all will receive 10 sessions of treadmill training for up to 10 min
at a self-selected speed over 5–6 weeks. The intervention group will receive real-time, visual biofeedback of
MTC during training and will be asked to modify their gait pattern to match a required “target” criterion.
Biofeedback is continuous for the first six sessions then progressively reduced (faded) across the remaining
four sessions. Control participants will walk on the treadmill without biofeedback. Gait assessments are
conducted at baseline, immediately following the final training session and then during follow-up, at one,
three, and six months. The primary outcome measure is MTC. Monthly falls calendars will also be collected
for 12 months from enrolment.
Discussion: The project will contribute to understanding how stroke-related changes to sensory and motor
processes influence gait biomechanics and associated tripping risk. The research findings will guide our work
in gait rehabilitation following stroke and may reduce falls rates. Treadmill training procedures incorporating
continuous real-time feedback may need to be modified to accommodate stroke patients who have greater
difficulties with treadmill walking.
Trial registration: Australia New Zealand Clinical Trials Registry, ACTRN12617000250336. Registered on 17
February 2017.
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Background
Stroke affects > 60,000 Australians every year, with 50%
unable to walk one week following the event [1]. Im-
paired walking impacts independence by reducing the
ability to perform everyday activities and limiting com-
munity participation [2, 3]. Falls risk is significantly
higher in people with chronic stroke [4] and approxi-
mately 50% of people living at home after a stroke will
fall within 12 months [9], with up to half sustaining mul-
tiple falls. Furthermore, in community-dwelling people
with stroke, up to 77% of falls occurred during walking.
While there has been considerable research investigating
falls risk management for older people generally,
high-risk groups, such as those who have had a stroke,
have not been extensively studied with respect to tar-
geted falls prevention. Traditional exercise-based
falls-prevention programs are useful for the general
older adult community but are not effective in people
with stroke. For example, Batchelor et al. found that a
multifactorial intervention including a home-based bal-
ance and strength program did not reduce falls in people
with stroke [10]. Another study confirmed that a group-
and home-based exercise program incorporating balance
and strength training did not reduce falls [11]. This sug-
gests that alternative, targeted treatments to reduce falls
risk in people with stroke are urgently needed.
Stroke adversely affects sensorimotor function and
muscle strength, inhibiting the capacity to activate ap-
propriate muscles and increasing the risk of contact be-
tween the foot and either the supporting surface or
objects on it. Said et al. [15] found, for example, that
stroke participants who had difficulty in stepping over
small obstacles (4 cm high) had greater falls rates. The
key gait variable for predicting tripping-falls is minimum
toe clearance (MTC), an event mid-swing in the walking
cycle [5–8]. Low MTC increases the probability of un-
anticipated foot-ground contacts [7]. Given that tripping
directly results from unsuccessful toe clearance, previous
research with both young and older populations has fo-
cused on toe trajectory control during walking [6–8, 12–
14]. Training individuals to increase MTC, therefore, has
potential as a falls-prevention intervention.
The aim of this project is to determine whether
real-time biofeedback of toe clearance during gait train-
ing can significantly minimize tripping risk in people
with stroke. We will test the efficacy of real-time bio-
feedback as an intervention to increase MTC using a
randomized controlled trial (RCT) design incorporating
both a training or “acquisition” phase with biofeedback.
Retention tests will be conducted to confirm learning, as
demonstrated by the longer-term or “relative perman-
ence” of the targeted behavior.
The primary objective is to determine whether
real-time biofeedback of MTC during gait training will
significantly increase MTC in people with stroke. We
will also determine whether changes in MTC achieved
on a treadmill transfer to overground walking. It is hy-
pothesized that, compared to no-biofeedback training,
visual biofeedback of foot clearance parameters during
gait training will significantly increase toe-ground
clearance (MTC) and MTC during biofeedback train-
ing will be retained in the longer term. It is also hy-
pothesized that increases in MTC demonstrated in
treadmill training will transfer to overground walking,
such that tripping-risk in people with stroke is signifi-
cantly reduced.
Methods/Design
This single-blinded parallel group RCT with 1:1
randomization will assess the effects of biofeedback on
MTC following gait training. It will conform to CON-
SORT guidelines and has been registered on the Austra-
lian and New Zealand Clinical Trials Registry
(ANZCTR): ACTRN12617000250336. Ethics approval
for the study was obtained from Austin Health, Mel-
bourne Health, and Victoria University Human Research
Ethics Committees. Informed consent procedures in-
clude the provision that participants clearly understand
that they are free to withdraw at any time without pro-
viding a reason. The study design flowchart is shown in
Fig. 1.
Patient population
Eligibility criteria for participants
Participants will be aged > 18 years, have sustained a sin-
gle stroke (ischemic or hemorrhagic) at least six months
previously, able to walk 50 m independently with or
without a single point stick, and capable of providing in-
formed consent. Exclusion criteria are: (1) an ankle foot
orthosis; (2) neurological, orthopedic, cardiac, respira-
tory, or other medical conditions in addition to stroke
that impact their ability to walk on a treadmill; (3) body
mass > 158 kg (due to the weight limit of the harness);
and (4) visual problems or severe visual-spatial neglect.
Participants will not be receiving physiotherapy for their
walking or lower limbs while enrolled in the study.
Participant recruitment study settings
Recruitment sites include Heidelberg Repatriation Hos-
pital (Austin Health), the Royal Melbourne Hospital
(Royal Park Campus), and Western Health. Interested
parties can also self-refer in response to advertising.
Gait assessments and training are conducted at the
Heidelberg Repatriation Hospital (Department of
Physiotherapy) and the Victoria University (Footscray
Park) Biomechanics Laboratory.
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Randomization
Randomization to participant group will be performed
by the project coordinator using a secure, web-based Re-
search Electronic Data Capture (REDCap) tool hosted at
Victoria University [26]. The participant group allocation
will then be e-mailed to the intervention therapist with
the subject heading Randomization of (Participant ID).
Participants will be coded and only available to autho-
rized project personnel.
Blinding
Clinical physiotherapists will be involved in assessment
but blinded to group allocation and training sessions.
Blinded clinical physiotherapists will conduct clinical as-
sessments and collect falls-related data. Biomechanical
gait assessors who conduct the movement analysis are,
similarly, blinded to group allocation to ensure that all
assessment personnel are blinded as to the participant’s
group assignment. Physiotherapists and biomechanists
delivering the gait training are required to know the pa-
tient’s group assignment.
Intervention
All participants, both controls and those in the feedback
intervention group, will walk on the treadmill following
an identical schedule of training sessions. Self-selected
walking speed will be determined following treadmill
familiarization with a physiotherapist during the first
clinical assessment visit. This self-selected walking speed
will be recorded and each treadmill walking session will
be conducted at the same walking speed. All participants
wear a safety harness when treadmill walking and con-
tinue for up to 10min with rest breaks as required. Pre-
vious research by the authors had determined 10 min to
be comfortable maximum for this population. Partici-
pants will wear the same comfortable shoes for all walk-
ing activities.
Participants randomized to the intervention group
undertake biofeedback gait-training using a real-time
display of the affected limb’s swing phase trajectory, with
toe clearance and the associated MTC event clearly
shown. Motion analysis markers will be attached to the
shoe and other body segments to calculate toe clearance
parameters in real-time as per the established protocol
[6]. Target MTC will be calculated as baseline MTC plus
1 SD. The feedback group will be asked to move their af-
fected limb such that MTC falls between target MTC
mean + 0.5SD and target MTC-0.5SD, projected as paral-
lel lines on a screen in front of the treadmill [16, 17]. If
baseline MTC cannot be calculated, target boundaries
will be set using the maximum toe clearance (TC) with
instructions to control foot motion within that target
Fig. 1 Study design flowchart
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band. Borg Ratings of Perceived Exertion will be re-
corded after each session.
Biofeedback is presented for the first six sessions then
progressively reduced (faded) across the remaining four
sessions. During fading, one-third of the initial feedback
will be available at the beginning of session 7, one-third
in the middle for session 8, one-third at the end of ses-
sion 9, and, finally, one-10th at the beginning and
one-10th at the end of session 10. As indicated above,
the control group will walk under the same conditions
without either feedback or any instructions concerning
their gait control. Adherence to the gait training pro-
gram will be reflected in the number of training sessions
successfully completed and the research team will moni-
tor any non-adherence.
Outcome measures
Assessments
A clinical assessment is conducted on the first visit
(baseline) in order to describe the study population.
Clinical assessments for global function, lower limb
strength, gait speed, and falls risk are repeated following
the final training session and at one, three, and six
months after training. Clinical measures undertaken by
the research physiotherapists will include:
 Functional Independence Measure (FIM) [18], a
measure of global function;
 Timed Chair Stand Test [20], an indicator of lower
limb strength;
 Timed 10-m Walk Test [19], an assessment of gait
speed;
 Step Test [21], a balance measure that identifies
stroke patients with a risk of falls;
 Sensory Testing (light touch, pinprick, and sensory
extinction);
 Star cancellation test; to screen for visual-spatial
neglect [27];
 Stroke Rehabilitation Assessment of Movement
(STREAM) [22], measures voluntary movement and
mobility in people with stroke;
 Tardieu scale [23], to assess spasticity in gastrocnemius
and soleus;
 Six-minute walk test [24], a measure of walking
endurance;
 Falls Risk for Older People in the Community
(FROP-Com). The FROP-Com has previously been
used to identify falls risk in people with stroke [10].
Gait assessment trials are conducted at baseline, after
the final training session (a minimum of 20 min follow-
ing final training) and one, three, and six months later.
These gait data are collected during treadmill and over-
ground walking by biomechanics personnel blinded to
group allocation. During overground walking assess-
ments (before and after training) participants walk at
preferred speed along an 8-m walkway. Kinematic (pos-
ition/time) data are captured using a three-dimensional
motion analysis system (Optotrak®, NDI, Canada) with
clusters of infrared markers fixed to the toe of the shoe
and the shank, thigh, and pelvis segments. Bony land-
marks on the foot, ankle, knee, and hip are identified
using virtual markers and used with the clusters in order
to construct a model of the joints and segments. This
enables kinematic data, including joint angles, to be cal-
culated. Foot plantar pressures and center of pressure
excursion (COPE) are captured to assess gait stability
using the Pedar foot pressure insole (Novel, Germany),
an in-shoe system that measures plantar pressure distri-
bution within the shoe.
Primary outcomes
The primary outcome variables from the motion ana-
lysis, MTC magnitude, and variability, will be assessed
using biomechanical assessment data at baseline and
after training, which occurs immediately following the
final training session after a minimum of 20 min rest.
Retention MTC data at one, three, and six months for
the affected limb will determine whether the target
MTC, i.e. baseline MTC plus 1 SD, has been maintained
after visual biofeedback training has concluded. The pre-
cise probability of tripping due to foot-ground contact
will be computed by statistically modelling the MTC
histogram [7].
Secondary outcomes
To supplement the MTC data, gait kinematics (second-
ary outcome variables) will be used to assess gait train-
ing effects on gait speed, stance/swing times, and joint
angles at key events, foot-contact, toe-off, and MTC of
the affected and unaffected limb. Baseline and retention
clinical data will show how falls risk measures were in-
fluenced by feedback training. The association between
the clinical tests and the biomechanical variables will be
shown by correlating tripping probability and clinical
measures. Medio-lateral and anterior-posterior foot
pressure (COPE) shifts will reveal biofeedback effects on
gait stability. A further secondary outcome is the num-
ber of falls following training. These data will be col-
lected via monthly falls calendars for 12 months from
enrolment in the study as illustrated in the SPIRIT study
timeline (Fig. 2).
Sample size calculations
In determining sample sizes, for the between-group com-
parisons, to detect differences in MTC a medium effect
size (ES = f = 0.25) between the group effects (No-Feed-
back versus Feedback) across the two time points
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(baseline and after training) a total of 126 or 63 per
group is required (G*Power [25] calculation, 2 × 2 re-
peated measures design, α = 0.05, power = 0.85, correl-
ation = 0.7). To allow a 20% drop-out, we shall
initially recruit 75 participants per group (N = 150).
This sample size will also allow detection of an in-
crease of 1 SD in MTC of the biofeedback group,
compared to their pre-training. The probability of
tripping [7] calculated using the pilot (stroke) partici-
pants’ data suggests that a 1 SD (0.77 cm) increase in
MTC will result in significant reduction in the risk of
tripping on small (1–2 cm) obstacles. A 0.77-cm in-
crease in MTC represents approximately a 50% gain
in minimum ground clearance (mean MTC = 1.4 cm)
that is shown by our modelling to represent a sub-
stantial decrease in tripping risk, i.e. the probability
of contacting an obstruction of a given height.
Data management and statistical analysis
All data will be stored via REDCap, an application spe-
cifically designed for the safe storage of clinical research
data, for seven years. Only research personnel associated
with the study will have access to the data and it will not
be available to external agencies. Optotrak, IMU, and
Pedar data will be coded so no personal information will
be identified in the data. De-identified data will also be
stored on a secure drive at the University. The patient’s
gait kinematics are monitored as the project progresses
to confirm no adverse effects of gait training, such as in-
creased tripping risk. External auditing is not required in
this study because all experimenters are trained to iden-
tify and record adverse events.
MTC data obtained from the treadmill walking will
be analyzed using two intervention group comparisons
and repeated measures ANOVA of the intervention
groups and change scores, with post-hoc comparisons
where relevant. Walking speed will be used as a
co-variate due to its influence on MTC data. The
between-subject factor will be treatment group
(No-feedback and Feedback) with Time (pre-training
baseline, post-training, one month, three months, and
six months) being the within-subject factor.
1) Between-group comparisons of MTC post-training
will reveal effectiveness of the biofeedback gait
training method in improving MTC.
Fig. 2 SPIRIT study timeline. T1 to T10 gait training sessions of (up to) 10min treadmill walking. Feedback (FB) group given visual feedback display of
minimum toe clearance (MTC), No-Feedback group given no gait-related information. Gait stability assessment from plantar pressures. Clinical Tests,
Borg Scales, and Falls Calendars: see text. Gait Bio. Baseline gait biomechanics variables for overground and treadmill walking, Fade MTC information
reduced progressively for FB group, COPE Centre of Pressure Excursion
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2) The within-subject analysis of the Feedback group
will reveal the biofeedback effects on MTC by
comparing each participant’s after intervention
(post-training) data to that obtained in retention
conditions, i.e. MTC data at one month (short-
term retention) and at three months and six months
(long-term retention).
3) MTC data collected during overground walking
during retention conditions will determine whether
any changes in MTC are translated to overground
walking.
Discussion
This innovative study will evaluate the impact of aug-
mented sensory information for improving gait function,
specifically foot-ground clearance, via visually presented
biofeedback. The research findings will contribute to the
broader falls prevention initiative by demonstrating the
effectiveness of toe clearance biofeedback in making
walking safer. It will also confirm whether faded
feedback enhances learning by demonstrating how
performance is affected immediately following training
and whether it can be retained in the long term. If
shown to be effective, there will be opportunities for
biofeedback-training applications to other gait-impaired
clinical populations. The project’s findings will contrib-
ute to understanding how stroke-related changes to sen-
sory and motor processes influence the tripping risks of
everyday walking. The protocol is, however, limited to
people with chronic stroke capable of walking on a
treadmill due to the continuous real-time feedback used
for gait training.
Trial status
Recruitment began on 27 April 2017 with Protocol Ver-
sion 6 dated 16 September 2016. Protocol Version 8
dated 20 June 2018 is currently in use following minor
amendments not affecting the implementation of the
project protocol. Recruitment is expected to be com-
pleted by 31 December 2020. Any important protocol
modifications will be formally communicated to relevant
parties by the chief investigator and the Protocol Version
updated.
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